Crossref
Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine
Advanced Neurology · 28.05.2026 · 026210021
DOI: 10.36922/an026210021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Neurology, online erschienen am 28.05.2026. Verfasst von Giorgia Sciacca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sciacca, G. (2026). Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine. Advanced Neurology, 0(0), 026210021. https://doi.org/10.36922/an026210021
Vancouver
Sciacca G. Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine. Advanced Neurology. 2026;0(0):026210021. doi:10.36922/an026210021
BibTeX
@article{Sciacca2026,
author = {Sciacca, Giorgia},
title = {Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine},
journal = {Advanced Neurology},
year = {2026},
volume = {0},
number = {0},
pages = {026210021},
doi = {10.36922/an026210021}
}
EUVIMED